首页> 美国卫生研究院文献>The Journal of Clinical Investigation >Vitamin D-dependent rickets type II. Defective induction of 25-hydroxyvitamin D3-24-hydroxylase by 125-dihydroxyvitamin D3 in cultured skin fibroblasts.
【2h】

Vitamin D-dependent rickets type II. Defective induction of 25-hydroxyvitamin D3-24-hydroxylase by 125-dihydroxyvitamin D3 in cultured skin fibroblasts.

机译:II型维生素D依赖性病。 125-二羟基维生素D3在培养的皮肤成纤维细胞中对25-羟基维生素D3-24-羟化酶的诱导缺陷。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

1,25(OH)2D3 induces 25(OH)D3-24-hydroxylase (24-OHase) in cultured skin fibroblasts from normal subjects. We evaluated 24-OHase induction by 1,25(OH)2D3 in skin fibroblasts from 10 normal subjects and from four unrelated patients with hereditary resistance to 1,25(OH)2D or vitamin D-dependent rickets type II (DD II). Fibroblasts were preincubated with varying concentrations of 1,25(OH)2D3 for 15 h and were then incubated with 0.5 microM [3H]25(OH)D3 at 37 degrees C for 30 min; lipid extracts of the cells were analyzed for [3H]24,25(OH)2D3 by high performance liquid chromatography and periodate oxidation. Apparent maximal [3H]24,25(OH)2D3 production in normal cell lines was 9 pmol/10(6) cells per 30 min and occurred after induction with 10(-8) M 1,25(OH)2D3. 24-OHase induction was detectable in normal fibroblasts at approximately 3 X 10(-10) M 1,25(OH)2D3. [3H]24,25(OH)2D3 formation after exposure to 1,25(OH)2D3 was abnormal in fibroblasts from all four patients with DD II. In fibroblasts from two patients with DD II, [3H]24,25(OH)2D3 formation was unmeasurable (below 0.2 pmol/10(6) cells per 30 min) at 1,25(OH)2D3 concentrations up to 10(-6) M. Fibroblasts from the other two patients with DD II required far higher than normal concentrations of 1,25(OH)2D3 for detectable [3H]24,25(OH)2D3 induction. In one, [3H]24,25(OH)2D3 production reached 2.9 pmol/10(6) cells per 30 min at 10(-6) M 1,25(OH)2D3 (30% normal maximum at 10(-6) M 1,25(OH)2D3). In the other, [3H]24,25(OH)2D3 production achieved normal levels, 7.3 pmol/10(6) cells per 30 min after 10(-6) M 1,25(OH)2D3. The two patients whose cells had a detectable 24-OHase induction by 1,25(OH)2D3 showed a calcemic response to high doses of calciferols in vivo. Our current observations correlate with these two patients' responsiveness to calciferols in vivo and suggest that their target organ defects can be partially or completely overcome with extremely high concentrations of 1,25(OH)2D3. The two patients whose cells showed no detectable 24-OHase induction in vitro failed to show a calcemic response to high doses of calciferols in vivo. In conclusion: (a) the measurement of 24-OHase induction by 1,25(OH)2D3 in cultured skin fibroblasts is a sensitive in vitro test for defective genes in the 1,25(OH)2D effector pathway. (b) This assay provides a useful tool for characterizing the target tissue defects in DD II and predicting response to calciferol therapy.
机译:1,25(OH)2D3在正常受试者的培养皮肤成纤维细胞中诱导25(OH)D3-24-羟化酶(24-OHase)。我们评估了皮肤成纤维细胞中1,25(OH)2D3对24-OHase的诱导作用,该成纤维细胞来自10名正常受试者和4名与1,25(OH)2D或II型维生素D依赖性病遗传相关的不相关患者。将成纤维细胞与不同浓度的1,25(OH)2D3预孵育15小时,然后与0.5 microM [3H] 25(OH)D3在37摄氏度孵育30分钟;通过高效液相色谱和高碘酸盐氧化分析细胞的脂质提取物的[3H] 24,25(OH)2D3。正常细胞系中最大的[3H] 24,25(OH)2D3表观产量为每30分钟9 pmol / 10(6)个细胞,并在诱导10(-8)M 1,25(OH)2D3之后出现。在大约3 X 10(-10)M 1,25(OH)2D3的正常成纤维细胞中检测到24-OHase诱导。四名DD II患者的成纤维细胞中,[3H] 24,25(OH)2D3暴露于1,25(OH)2D3形成异常。在来自两名DD II患者的成纤维细胞中,[3H] 24,25(OH)2D3的形成在1,25(OH)2D3浓度高达10(-)时无法测量(每30分钟低于0.2 pmol / 10(6)个细胞)。 6)来自其他两名DD II患者的成纤维细胞对可检测的[3H] 24,25(OH)2D3诱导所需的浓度远高于正常浓度的1,25(OH)2D3。在一种情况下,在10(-6)M 1,25(OH)2D3(30%正常最大值在10(-6)下,每30分钟产生[3H] 24,25(OH)2D3产量达到2.9 pmol / 10(6)个细胞)M 1,25(OH)2D3)。另一方面,[3H] 24,25(OH)2D3的生产达到正常水平,即10(-6)M 1,25(OH)2D3后每30分钟7.3 pmol / 10(6)个细胞。两名患者的细胞在1,25(OH)2D3中具有可检测到的24-OHase诱导,这表明它们对体内高剂量的钙化甾醇具有钙化反应。我们目前的观察结果与这两名患者体内对钙化甾醇的反应性相关,并表明,使用极高浓度的1,25(OH)2D3可以部分或完全克服其目标器官缺陷。两名患者的细胞在体外均未显示出可检测到的24-OHase诱导,但未能在体内显示出对高剂量钙化甾醇的钙减少反应。结论:(a)在培养的皮肤成纤维细胞中由1,25(OH)2D3诱导的24-OHase诱导是对1,25(OH)2D效应子途径中缺陷基因的敏感的体外测试。 (b)该测定法提供了有用的工具,可用于表征DD II中的靶组织缺损并预测对钙化甾醇治疗的反应。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号